National Hog Farmer is announcing a webinar, "Role of vaccine-derived immunity for PRRS control: three perspectives," to be held September 26, 2022, 2:00 PM EDT.
Over the last 25 years, swine producers have battled the challenge of porcine reproductive and respiratory syndrome virus (PRRSV), relying on many of the same tools since the beginning. While these tools are still effective, PRRS control continues to be a challenge due to new strains, leaving many producers frustrated and yearning for innovation. While some emerging strains may be more challenging than others, research and experience in the field have shown us that managing any strain of PRRSV comes down to the basic principles of biosecurity and immunity the industry is already familiar with.
This webinar will provide an overview of our current understanding of PRRS immunology and vaccine-derived immunity, digging into how we are applying learnings from the most current field-applicable research and, finally, revealing how veterinarians and producers are not only flexing current tools for successful PRRSV management, but also finding opportunities for innovation.
Three swine industry experts will contribute to this webinar, offering three unique perspectives that encompass the key aspects of PRRSV management including an immunotherapeutics scientist perspective, a researcher perspective, and a veterinarian perspective.
Attend this webinar and learn:
- The critical role of vaccine-derived immunity in protecting pigs against PRRS, including what it means and why it matters.
- How longstanding tools for PRRS protection are being flexed and used in different ways.
- Best practices and tips for creating immunity in pigs.
- Why the basic principles of PRRS control – maximizing immunity, minimizing exposure and transmission, and measuring and monitoring through diagnostics – remain relevant and effective 25 years later.
Sponsored by Boehringer Ingelheim.
Don’t wait, register now!